Icu Medical [ICUI] vs Becton, Dickinson [BDX] Detailed Stock Comparison
Icu Medical
NASDAQ
Loading...
Becton, Dickinson
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Icu Medical wins in 6 metrics, Becton, Dickinson wins in 13 metrics, with 0 ties. Becton, Dickinson appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Icu Medical | Becton, Dickinson | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -26.49 | 35.52 | Icu Medical |
| Price-to-Book Ratio | 1.58 | 2.08 | Icu Medical |
| Debt-to-Equity Ratio | 80.57 | 76.34 | Becton, Dickinson |
| PEG Ratio | 18.65 | 11.63 | Becton, Dickinson |
| EV/EBITDA | 13.27 | 12.74 | Becton, Dickinson |
| Profit Margin (TTM) | -3.87% | 7.18% | Becton, Dickinson |
| Operating Margin (TTM) | 4.89% | 16.01% | Becton, Dickinson |
| EBITDA Margin (TTM) | 4.89% | 16.01% | Becton, Dickinson |
| Return on Equity | -4.62% | 5.89% | Becton, Dickinson |
| Return on Assets (TTM) | 1.79% | 3.69% | Becton, Dickinson |
| Free Cash Flow (TTM) | $113.83M | $3.07B | Becton, Dickinson |
| Dividend Yield | N/A | 1.80% | N/A |
| 1-Year Return | -0.34% | -24.94% | Icu Medical |
| Price-to-Sales Ratio (TTM) | 1.30 | 2.51 | Icu Medical |
| Enterprise Value | $4.44B | $71.02B | Becton, Dickinson |
| EV/Revenue Ratio | 1.84 | 3.40 | Icu Medical |
| Gross Profit Margin (TTM) | 34.75% | 42.81% | Becton, Dickinson |
| Revenue per Share (TTM) | $99 | $72 | Icu Medical |
| Earnings per Share (Diluted) | $-3.82 | $5.15 | Becton, Dickinson |
| Beta (Stock Volatility) | 0.87 | 0.28 | Becton, Dickinson |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Icu Medical vs Becton, Dickinson Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Icu Medical | -0.99% | -2.74% | -5.05% | -8.14% | -24.37% | -20.58% |
| Becton, Dickinson | -0.46% | -0.57% | 5.39% | -12.34% | -26.94% | -19.85% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Icu Medical | -0.34% | -30.15% | -29.39% | 25.86% | 248.24% | 316.71% |
| Becton, Dickinson | -24.94% | -28.59% | -27.43% | 24.95% | 159.60% | 244.22% |
Performance & Financial Health Analysis: Icu Medical vs Becton, Dickinson
| Metric | ICUI | BDX |
|---|---|---|
| Market Information | ||
| Market Cap | $3.13B | $52.43B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 164,567 | 3,076,710 |
| 90 Day Avg. Volume | 205,399 | 2,990,843 |
| Last Close | $125.47 | $181.54 |
| 52 Week Range | $117.92 - $196.26 | $163.33 - $251.99 |
| % from 52W High | -36.07% | -27.96% |
| All-Time High | $321.70 (Aug 06, 2018) | $287.32 (Jul 24, 2023) |
| % from All-Time High | -61.00% | -36.82% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.05% |
| Quarterly Earnings Growth | 0.07% | -0.43% |
| Financial Health | ||
| Profit Margin (TTM) | -0.04% | 0.07% |
| Operating Margin (TTM) | 0.05% | 0.16% |
| Return on Equity (TTM) | -0.05% | 0.06% |
| Debt to Equity (MRQ) | 80.57 | 76.34 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $80.76 | $88.07 |
| Cash per Share (MRQ) | $12.11 | $2.38 |
| Operating Cash Flow (TTM) | $209.57M | $3.30B |
| Levered Free Cash Flow (TTM) | $77.29M | $3.50B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.80% |
| Last 12-Month Dividend | N/A | $3.03 |
Valuation & Enterprise Metrics Analysis: Icu Medical vs Becton, Dickinson
| Metric | ICUI | BDX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -26.49 | 35.52 |
| Forward P/E | 18.65 | 11.63 |
| PEG Ratio | 18.65 | 11.63 |
| Price to Sales (TTM) | 1.30 | 2.51 |
| Price to Book (MRQ) | 1.58 | 2.08 |
| Market Capitalization | ||
| Market Capitalization | $3.13B | $52.43B |
| Enterprise Value | $4.44B | $71.02B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.84 | 3.40 |
| Enterprise to EBITDA | 13.27 | 12.74 |
| Risk & Other Metrics | ||
| Beta | 0.87 | 0.28 |
| Book Value per Share (MRQ) | $80.76 | $88.07 |
Financial Statements Comparison: Icu Medical vs Becton, Dickinson
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ICUI | BDX |
|---|---|---|
| Revenue/Sales | $604.70M | $5.27B |
| Cost of Goods Sold | $394.59M | $3.02B |
| Gross Profit | $210.11M | $2.26B |
| Research & Development | $23.29M | $302.00M |
| Operating Income (EBIT) | $29.59M | $637.00M |
| EBITDA | $82.47M | $1.21B |
| Pre-Tax Income | $-10.91M | $363.00M |
| Income Tax | $4.57M | $55.00M |
| Net Income (Profit) | $-15.48M | $308.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ICUI | BDX |
|---|---|---|
| Cash & Equivalents | $289.70M | $667.00M |
| Total Current Assets | $1.42B | $8.67B |
| Total Current Liabilities | $549.02M | $7.69B |
| Long-Term Debt | $1.54B | $17.67B |
| Total Shareholders Equity | $1.99B | $25.24B |
| Retained Earnings | $674.68M | $16.15B |
| Property, Plant & Equipment | $466.20M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ICUI | BDX |
|---|---|---|
| Operating Cash Flow | $90.80M | $941.00M |
| Capital Expenditures | $-14.62M | N/A |
| Free Cash Flow | $34.47M | $35.00M |
| Debt Repayment | $-48.08M | $-1.00M |
| Common Stock Repurchase | N/A | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | ICUI | BDX |
|---|---|---|
| Shares Short | 1.18M | 4.69M |
| Short Ratio | 5.25 | 1.49 |
| Short % of Float | 0.06% | 0.02% |
| Average Daily Volume (10 Day) | 164,567 | 3,076,710 |
| Average Daily Volume (90 Day) | 205,399 | 2,990,843 |
| Shares Outstanding | 24.52M | 289.10M |
| Float Shares | 23.85M | 285.93M |
| % Held by Insiders | 0.03% | 0.01% |
| % Held by Institutions | 1.01% | 0.93% |
Dividend Analysis & Yield Comparison: Icu Medical vs Becton, Dickinson
| Metric | ICUI | BDX |
|---|---|---|
| Last 12-Month Dividend | N/A | $3.03 |
| Last 12-Month Dividend Yield | N/A | 1.80% |
| 3-Year Avg Annual Dividend | N/A | $3.16 |
| 3-Year Avg Dividend Yield | N/A | 0.40% |
| 3-Year Total Dividends | N/A | $9.48 |
| Ex-Dividend Date | N/A | Mar 10, 2025 |